{
"resourceType": "MedicinalProductIndication", "id": "example", "diseaseSymptomProcedure": { "coding": [ { "system": "http://ema.europa.eu/example/indicationasdisease-symptom-procedure", "code": "Venousthromboembolismprophylaxis" } ], "text": "Prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective hip\\nor knee replacement surgery.\\nPrevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation\\n(NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age\\n≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).\\nTreatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent\\nDVT and PE in adults (see section 4.4 for haemodynamically unstable PE patients)." }, "comorbidity": [ { "coding": [ { "system": "http://ema.europa.eu/example/comorbidity", "code": "Hipsurgery" } ] } ], "intendedEffect": { "coding": [ { "system": "http://ema.europa.eu/example/intendedeffect", "code": "PRYLX" } ] }, "population": [ { "ageRange": { "low": { "value": 18, "unit": "a" } } } ], "meta": { "tag": [ { "system": "http://terminology.hl7.org/CodeSystem/v3-ActReason", "code": "HTEST", "display": "test health data" } ] }
}